Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.8488
-0.1612 (-15.96%)
At close: Oct 7, 2026, 4:00 PM EDT
0.8544
+0.0056 (0.66%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Pomdoctor Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 410.45 | 399.91 | 342.56 | 304.85 | 245.22 | 215.38 | |
Revenue Growth | 11.88% | 16.74% | 12.37% | 24.32% | 13.85% | 52.53% |
Cost of Revenue | 361.21 | 347.63 | 294.86 | 266.13 | 190.36 | 162.88 |
Gross Profit | 49.24 | 52.28 | 47.69 | 38.72 | 54.86 | 52.51 |
Selling, General & Admin | 269.56 | 155.94 | 68.24 | 55.99 | 54.87 | 102.95 |
Research & Development | 117.66 | 12.86 | 3 | 3.37 | 3.59 | 4.28 |
Operating Expenses | 387.22 | 168.81 | 71.25 | 59.36 | 58.46 | 107.23 |
Operating Income | -337.98 | -116.53 | -23.55 | -20.64 | -3.59 | -54.73 |
Interest Expense | -12.54 | -12.89 | -12.96 | -13.85 | -16.02 | -16.29 |
Other Non Operating Income (Expenses) | 1.89 | 0.59 | 1.39 | -0.85 | -0.21 | -0.22 |
EBT Excluding Unusual Items | -348.63 | -128.82 | -35.13 | -35.34 | -19.83 | -71.24 |
Gain (Loss) on Sale of Investments | - | - | - | -0.5 | - | - |
Asset Writedown | -0.52 | -2.11 | -2.24 | -1.11 | - | -24.94 |
Other Unusual Items | -29.24 | -81.65 | -105.97 | -108.44 | -105.68 | -92.24 |
Pretax Income | -378.39 | -212.58 | -143.34 | -145.39 | -125.51 | -188.42 |
Income Tax Expense | 0.07 | 0 | - | - | - | - |
Earnings From Continuing Operations | -378.46 | -212.58 | -143.34 | -145.39 | -125.51 | -188.42 |
Minority Interest in Earnings | 8.39 | 0 | -0.03 | -0 | 0 | 0.02 |
Net Income | -370.07 | -212.58 | -143.36 | -145.39 | -125.51 | -188.4 |
Net Income to Common | -370.07 | -212.58 | -143.36 | -145.39 | -125.51 | -188.4 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 3 | 2 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 6 | 3 | 2 | 2 | 1 | 1 |
Shares Change | 143.37% | 53.41% | - | 56.11% | - | -76.35% |
EPS (Basic) | -61.28 | -65.88 | -68.16 | -69.12 | -93.15 | -139.83 |
EPS (Diluted) | -61.28 | -65.88 | -68.16 | -69.12 | -93.15 | -139.83 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -124.84 | -150.09 | -16.17 | -45.91 | -22.02 | -15.68 |
Free Cash Flow Per Share | -20.67 | -46.51 | -7.69 | -21.82 | -16.34 | -11.64 |
Gross Margin | 12.00% | 13.07% | 13.92% | 12.70% | 22.37% | 24.38% |
Operating Margin | -82.35% | -29.14% | -6.88% | -6.77% | -1.47% | -25.41% |
Profit Margin | -90.16% | -53.16% | -41.85% | -47.69% | -51.18% | -87.47% |
Free Cash Flow Margin | -30.42% | -37.53% | -4.72% | -15.06% | -8.98% | -7.28% |
EBITDA | -337.78 | -116.38 | -23.42 | -20.53 | 14.08 | -37.05 |
EBITDA Margin | -82.30% | -29.10% | -6.84% | -6.73% | 5.74% | -17.20% |
D&A For EBITDA | 0.21 | 0.15 | 0.13 | 0.11 | 17.68 | 17.68 |
EBIT | -337.98 | -116.53 | -23.55 | -20.64 | -3.59 | -54.73 |
EBIT Margin | -82.35% | -29.14% | -6.88% | -6.77% | -1.47% | -25.41% |
Revenue as Reported | 410.45 | 399.91 | 342.56 | 304.85 | 245.22 | - |
Advertising Expenses | - | 19.54 | 11.1 | 3.43 | 1.37 | 7.29 |